Overview of the Industry: A World of Opportunities

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001

The time is ripe to further a pharmaceutical career in the United States. The industry is full of promising opportunities for people eager to contribute and advance.

Articles in this issue
Overview of the Industry: A World of Opportunities
I Have A Dream: Communicating a Vision Helps Managers Become Leaders
Challenges to Diversity: Recruiting and Retaining Minorities
On the Right Path: Sales Careers in Pharma
Surviving a Merger: HBA Takes a Look
Recent Videos
Related Content
Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

PharmExec Staff
April 4th 2025
Article

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."

Mark Frohlich: A ‘Natural’ Leader

Mark Frohlich: A ‘Natural’ Leader

Mike Hollan
March 13th 2025
Article

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.

Elaina Shekhter, EPAM Chief Marketing & Strategy Officer.

Preparing for the C-Suite

Michael Wong
March 13th 2025
Article

A Harvard Business School Healthcare Alumni Association Q&A with Elaina Shekhter, EPAM’s Chief Marketing & Strategy Officer.

The ‘People Factor’: Sourcing, Nurturing, and Retaining Talent

The ‘People Factor’: Sourcing, Nurturing, and Retaining Talent

Jamie Pallot
March 12th 2025
Article

Experts weigh in on today’s life sciences leadership-development priorities critical to long-term success.

Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

PE Staff
February 14th 2025
Article

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial intelligence in the drug discovery process.

The Teva Turnaround: Steering a Company Comeback

The Teva Turnaround: Steering a Company Comeback

Michael Christel
February 11th 2025
Article

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to recapture the heights of old.